-
Production approval of 6 kinds of cefmetazole sodium APIs for Fuan pharmaceutical industry
Time of Update: 2020-04-03
Fuan Pharmaceutical Co., Ltd announced in the evening of the 26th that the company's six kinds of chemical drugs "Cefmetazole sodium" APIs have recently been received from the State Food and Drug Admi
-
Humanwell medical and biological products are approved to enter the clinical phase II trial
Time of Update: 2020-04-03
Humanwell pharmaceutical announced today that the recombinant plasmid hepatocyte growth factor injection developed by Wuhan Guanggu humanwell biomedical Co., Ltd (humanwell pharmaceutical holds 32.52%
-
Xiamen Tebao new drug pegylated interferon α - 2b injection is the first in China to be approved soon
Time of Update: 2020-04-03
According to the information on CFDA's website on November 5, Tonghua Dongbao (600867 SH), a joint-stock company of Xiamen Tebao, will enter the GMP field inspection this month Industry insiders predi
-
Zaiding Pharmaceutical Co., Ltd. and South Korea and the United States jointly develop EGFR targeted lung cancer drug hm61713
Time of Update: 2020-04-03
It is reported that hm61713 is the third generation irreversible tyrosine kinase inhibitor targeting EGFR mutation, targeting at T790M mutant tumors At the 2015 ASCO annual meeting, South Korea and th
-
Key technology of modern preparation of traditional Chinese medicine won the first prize of Tianjin Science and Technology Progress Award
Time of Update: 2020-04-03
To develop a new drug in the field of traditional Chinese medicine, it is often necessary to understand the chemical composition, identify the efficacy, human metabolism research and other aspects of
-
FDA Approves the clinical trial of Baiji Shenzhou anticancer drug bgb-3111 in the United States
Time of Update: 2020-04-03
June 24, 2015 / BIOON / - Baiji Shenzhou has obtained the application of FDA new drug research (ind), and will conduct bgb-3111 clinical research Bgb-3111 is a specific inhibitor of bruston's tyrosine
-
Drug research and development is becoming increasingly difficult new pharmaceutical excipients research and development to promote the development of dosage forms
Time of Update: 2020-04-03
In recent years, the research and development of new drugs are becoming more and more difficult, which leads to the research of innovative drugs gradually turning to the development of new drug prepar
-
New products will be produced on R & D platform of single anti drug of Fosun Pharmaceutical banner
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 30, Fuhong Hanlin, a subsidiary of Fosun Pharmaceutical holding company, applied for the clinical application of class
-
Biopharmaceutical - imitation success is also a high-tech NB industry!
Time of Update: 2020-04-03
What is the biological similar drug? First, introduce the difference between the original research drug (also called patent drug) and the generic drug Patent medicine is a kind of medicine produced by
-
Aosaikang declared 3.1 antifungal carbaryl acetate API
Time of Update: 2020-04-03
According to the CFDA website on March 27, the API of kapofungin acetate, a class 3.1 new drug, which was applied for production by arcmecon, was accepted At present, only the original drug kapofungin
-
Two projects in Inner Mongolia were supported by the national science and technology major project of "major new drug creation"
Time of Update: 2020-04-03
Two projects of Inner Mongolia Autonomous Region were supported by the national science and technology major project of "major new drug creation", among which "research and development of new and high
-
On site inspection of low molecular weight heparin calcium API of Dongcheng pharmaceutical
Time of Update: 2020-04-03
According to the information on January 26 on the website of the State Food and Drug Administration (CFDA), Dongcheng pharmaceutical's key product, low molecular weight heparin calcium API, has entere
-
Changchun hi tech subsidiary's Baike biological herpes zoster live attenuated vaccine obtained clinical approval
Time of Update: 2020-04-03
Changchun hi tech announced on July 6 that the biological product "live attenuated herpes zoster vaccine" declared by Baike biology, the holding subsidiary of the company, has been approved for clinic
-
China's new drug research and development progress in May 2014
Time of Update: 2020-04-03
1 Chemical drugs 1.1 research and development progress, drug name, action target, indication, manufacturer category Clinical asc08 NS3 / 4A declared by Haikou pharmaceutical factory of liver and kidney fibrosis Clinical application of proteinase inhibitor HCV infection with Geli biological for fg-4592 hif-ph inhibitor chronic nephropathy , end-stage renal disease Beijing fabojin declare clinical flumatinib BCR ABL inhibitor chronic myeloid leukemia Jiangsu Haosen Pharmaceutical Co., Ltd approved the production of?
-
China's EV71 inactivated vaccine against HFMD has entered the final stage of evaluation
Time of Update: 2020-04-03
Wang Lifeng, director of CFDA pharmaceutical and chemical department, introduced at a press conference on the morning of July 4 that the clinical trials of EV71 inactivated (Vero cell) vaccine for the
-
Wuzhou Pharmaceutical Co., Ltd. and dema Co., Ltd. are still in the phase II clinical stage of FDA
Time of Update: 2020-04-03
At the annual performance presentation meeting on May 8, Zhongheng group said that Wuzhou pharmaceutical, a subsidiary of Zhongheng group, cooperated with dema company to carry out the FDA clinical ce
-
Boya biological declared clinical class 1 biological products for treatment of HFMD (EV71) human immunoglobulin accepted
Time of Update: 2020-04-03
According to the information on July 2 on the website of the State Food and Drug Administration (CFDA), the human immunoglobulin of class 1 therapeutic biological product hand foot mouth disease (EV71
-
Apatinib, a class 1.1 new drug of Hengrui medicine, is expected to be approved within one year after entering the site for inspection
Time of Update: 2020-04-03
According to the information on June 3 on the website of the State Food and Drug Administration (CFDA), apatinib, a 1.1 new drug of Hengrui pharmaceutical, is in the stage of waiting for on-site inspe
-
Puluo Pharmaceutical Co., Ltd. signed a technical cooperation development contract with West China Hospital of Sichuan University on "targeted histone modified new antitumor drugs"
Time of Update: 2020-04-03
In order to promote the development of the company in the field of anti-cancer and support the "major science and technology projects for new drug creation" of the state, PLO pharmaceutical announced
-
Kangyuan pharmaceutical's exclusive variety of Cistanche total glycoside capsule in the treatment of vascular dementia has obtained new drug certificate
Time of Update: 2020-04-03
According to the information on the website of the State Food and Drug Administration (CFDA) on July 1, the review status of the exclusive product of Kangyuan pharmaceutical, Cistanche total glycoside
